Mangoceuticals, Inc.
NCM: MGRXLive Quote
📈 ZcoreAI Score
Our AI model analyzes Mangoceuticals, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get MGRX Z-Score →About Mangoceuticals, Inc.
Healthcare
Health Information Services
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
📊 Fundamental Analysis
Mangoceuticals, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
The company recently reported -10.3% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is -141.7%, which indicates that capital utilization is currently under pressure.
At a current price of $0.34, MGRX currently trades near the bottom of its 52-week range (7%), indicating potential value or weakness (Range: $0.16 - $2.88).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
🔴
Revenue Growth
Weak
🔴
Return on Equity
Weak
🔴
Beta (Risk)
High Volatility
Key Financials
Market Cap
$5.77M
Trailing P/E
--
Forward P/E
--
Beta (5Y)
2.55
52W High
$2.88
52W Low
$0.16
Avg Volume
12.90M
Day High
Day Low